BIOSPECIFICS TECHNOLOGIES CORP (BSTC.PK) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 104 transactions totaling $971.2K, demonstrating a bearish sentiment with -$218.8K in net insider flow. The most recent transaction on Mar 17, 2008 involved a sale of 50,000 shares valued at $595.0K.
No significant insider buying has been recorded for BSTC.PK in the recent period.
No significant insider selling has been recorded for BSTC.PK in the recent period.
Based on recent SEC filings, insider sentiment for BSTC.PK is bearish with an Insider Alignment Score of 39/100 and a net flow of -$218.8K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at BIOSPECIFICS TECHNOLOGIES CORP (BSTC.PK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading BSTC.PK stock, having executed 104 transactions in the past 90 days. The most active insider is Michael Schamroth (Executive), who has made 2 transactions totaling $615.0K.
Get notified when executives and directors at BSTC.PK file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 17, 2008 | Schamroth Michael | Executive | Sale | 50,000 | $11.90 | $595.0K | Large |
| Nov 15, 2007 | Schamroth Michael | Executive | Exercise | 20,000 | $1.00 | $20.0K | |
| Aug 17, 2007 | Wegman Thomas | Executive | Exercise | 1,000 | $3.88 | $3.9K | |
| Jul 18, 2007 | Kenneth Vogel Jeffrey | Executive | Purchase | 2,000 | $4.60 | $9.2K | |
| Jul 17, 2007 | Kenneth Vogel Jeffrey | Executive | Purchase | 1,000 | $4.60 | $4.6K | |
| Jul 13, 2007 | Kenneth Vogel Jeffrey | Executive | Purchase | 500 | $4.60 | $2.3K | |
| Jul 13, 2007 | Wegman Thomas | Executive | Will Acquisition | 2,048,442 | $N/A | $0 | |
| Jul 12, 2007 | Kenneth Vogel Jeffrey | Executive | Purchase | 500 | $4.55 | $2.3K | |
| Jul 10, 2007 | Kenneth Vogel Jeffrey | Executive | Purchase | 1,000 | $4.60 | $4.6K | |
| Jul 9, 2007 | Kenneth Vogel Jeffrey | Executive | Purchase | 1,000 | $4.60 | $4.6K | |
| Jun 22, 2007 | Kenneth Vogel Jeffrey | Executive | Purchase | 23 | $4.55 | $105 | |
| Jun 20, 2007 | Kenneth Vogel Jeffrey | Executive | Purchase | 20 | $4.55 | $91 | |
| Jun 18, 2007 | Kenneth Vogel Jeffrey | Executive | Purchase | 500 | $4.55 | $2.3K | |
| Jun 15, 2007 | Kenneth Vogel Jeffrey | Executive | Purchase | 1,000 | $4.55 | $4.5K | |
| Jun 13, 2007 | Kenneth Vogel Jeffrey | Executive | Purchase | 1,500 | $4.55 | $6.8K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 1 | $595.0K | 58.9% |
Purchase(P) | 99 | $376.2K | 37.2% |
Exercise (Options)(X) | 2 | $23.9K | 2.4% |
Award(A) | 1 | $15.0K | 1.5% |
Will Acquisition(W) | 1 | $0 | 0.0% |
Insider selling pressure at BIOSPECIFICS TECHNOLOGIES CORP has increased, with 4 insiders executing 104 transactions across all time. Total sales of $595.0K significantly outpace purchases of $376.2K, resulting in a net outflow of $218.8K. This selling activity appears largely discretionary, which may warrant closer attention from investors.